According to a 2021 review, nail psoriasis can be challenging to treat, but treatment is possible. The best approach for you may depend on your specific symptoms and their severity. Keep reading ...
The patches show up on the arms, legs, and torso area ... which will require long-term treatment. Guttate psoriasis can emerge temporarily and often goes away on its own. But it’s good to ...
There is good evidence that alcohol consumption can considerably worsen psoriasis. One of my favourite natural treatments for psoriasis are the healthy dietary fats known as essential fatty acids.
Those most likely to benefit from such a treatment are patients with pustular psoriasis (PP) – a particularly severe and treatment-resistant form of the disease that can affect a patient’s ...
Home-based phototherapy for plaque and guttate psoriasis is as effective as office-based phototherapy, results of the ...
Though psoriasis affects people of all skin tones, that diversity isn’t always represented in portrayals of the condition in ...
Brodalumab is an effective therapy among patients with psoriasis who have failed prior biologic therapy or had risk factors for treatment failure.
Those most likely to benefit from such a treatment are patients with pustular psoriasis (PP)—a particularly severe and treatment-resistant form of the disease that can affect a patient's nails ...
These 28-week data on twice-daily ESK-001 highlight the drug’s safety and efficacy among patients with psoriasis.
A2302E1 is an extension of pivotal phase 3 studies ERASURE and FIXTURE made up of a double-blind, placebo-controlled study of 120 psoriasis patients. After one year of Cosentyx treatment ...
The research may have implications for the treatment of hard-to-heal ... A Cure for Psoriasis: Could a Faulty Iron Hormone in the Skin Be the Key? Sep. 26, 2024 — Scientists believe the hormone ...
The phase 2b study showed zasocitinib reduced psoriasis severity and improved ... How does the introduction of zasocitinib as a treatment option align with improving long-term patient outcomes ...